Patents by Inventor Jinfeng Wei

Jinfeng Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11954986
    Abstract: A self-service apparatus having a three-layer system architecture includes an application-layer device, an intermediate-layer device, and bottom-layer peripheral devices. The application-layer device is configured to provide a user interface for self-service and control the entire self-service apparatus according to an interaction with the user to provide the user with required self-service, and comprises a first processor and a first memory. The first processor executes an application program stored in the first memory and communicates with the intermediate-layer device. The intermediate-layer device comprises a terminal control module which comprises a second processor and a second memory. The second processor communicates with the bottom-layer peripheral devices, and the second processor executes a control program stored in the second memory to control operations of the peripheral devices based on an instruction from the application-layer device.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: April 9, 2024
    Assignee: Elo Touch Solutions, Inc.
    Inventors: Yin Sun, Xueqing Wei, Jinfeng Zhang, Hua Shao
  • Patent number: 10058611
    Abstract: The present invention relates to a use of alpha-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis. The use is suitable for various type of psoriasis by utilizing photodynamic therapy. The photosensitizer is used to treat psoriasis by utilizing laser wave length of 670 nm, with high light sensitivity, fast photobleaching, short time needed in protection from light, and avoiding potential toxic and side-effect of photochemistry therapy by using ultraviolet irradiation. The preparation used in the use of ?-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis includes solution, cream, nanomicelle, microsphere etc, and mode of administration can be systemic or topical administration. The practicability of treating psoriasis by photodynamic therapy has been validated on cell and animal model. The use achieves perfect effect.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: August 28, 2018
    Assignee: BEIJING GUIQIANJIN MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Hanqing Liu, Aiping Wang, Jinfeng Wei, Hongtao Jin, Qianaian Zhang, Ni Lin, Zhihuan Jiang, Xiaodan Yan, Ye Li, Jingyi Feng, Yingming Wang
  • Publication number: 20170296662
    Abstract: The present invention relates to a use of alpha-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis. The use is suitable for various type of psoriasis by utilizing photodynamic therapy. The photosensitizer is used to treat psoriasis by utilizing laser wave length of 670 nm, with high light sensitivity, fast photobleaching, short time needed in protection from light, and avoiding potential toxic and side-effect of photochemistry therapy by using ultraviolet irradiation. The preparation used in the use of ?-(8-quinolinyloxy) mono-substituted phthalocyanine zinc for the treatment of psoriasis includes solution, cream, nanomicelle, microsphere etc, and mode of administration can be systemic or topical administration. The practicability of treating psoriasis by photodynamic therapy has been validated on cell and animal model. The use achieves perfect effect.
    Type: Application
    Filed: September 2, 2014
    Publication date: October 19, 2017
    Inventors: Hanqing Liu, Aiping Wang, Jinfeng Wei, Hongtao Jin, Qianaian Zhang, Ni Lin, Zhihuan Jiang, Xiaodan Yan, Ye Li, Jingyi Feng, Yingming Wang